AstraZeneca Sues Accord Over Seroquel
The company filed suit Friday against Accord Healthcare Inc. and its Indian parent company, Intas Pharmaceutical Ltd., in the U.S. District Court for the District of New Jersey. The suit alleges that Accord's abbreviated new drug application infringes the key patent for Seroquel.
The patent at issue is U.S. Patent number 5,948,437, which expires in 2017.
According to the suit, Accord sent AstraZeneca a letter on...
To view the full article, register now.